Blepharoplasty Market Expected to Reach $7.2 billion by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Blepharoplasty Market," The blepharoplasty market size was valued at $3.4 billion in 2021, and is projected to reach $7.2 billion by 2031, growing at a CAGR of 7.6% from 2022 to 2031. Blepharoplasty is a type of plastic surgery for upper and lower eyelids in which skin and fat are removed or added, respectively. In this surgery thin stitches are given to establish an eyelid crease after the incision is made to remove extra skin or fat during upper eyelid surgery. In lower eyelid surgery, the incision is made directly beneath the lash line or on the inside of the eyelid, commonly referred to as a transconjunctival approach. In addition, blepharoplasty is combined with laser resurfacing of the eyelid skin to get rid of wrinkles and creases.  

The key blepharoplasty market trends include rise in awareness and adoption of technologically advanced non-invasive surgical procedures. Furthermore, increase in elderly population is more susceptible to develop disorders related to the face and eyelids, which results in market growth. For instance, according to the World Health Organization, by 2030, one in six people in the world will be aged 60 years or older and the share of the population aged 60 years and above will increase from 1 billion in 2020 to 1.4 billion. Thus, increase in number of geriatric populations is expected to drive the growth during blepharoplasty market forecast.  

Furthermore, technological advancement has led to the use of minimally invasive methods such as CO2 lasers and dermal fillers such as hyaluronic acid and Botox in a variety of medical and cosmetic procedures such as blepharoplasty. This procedure typically takes between 1-2 hours to complete, and thus getting more preference from patients. Increase in the adoption of minimally invasive surgery is thus expected to further boost the blepharoplasty market size. 

In addition, the market for blepharoplasty is expected to develop due to an increase in clinics equipped with advance technology and the number of experts performing surgical procedures. In addition, the rise in disposable income among the population of developing nations and an increase in R&D activities, offers lucrative growth opportunities to key market players and contribute to the expansion of the market. 

Furthermore, key players in the market have invested in the R&D of the blepharoplasty procedure and have also adopted key strategies such as acquisitions to cater to the demand for non-invasive procedures. For instance, in October 2020, Allergan Aesthetics, a research-based pharmaceutical company, entered into an agreement with Luminera, a privately held aesthetics company with a portfolio and pipeline of dermal filler products, to enhance the dermal filler portfolio of the company in international and the U.S. markets. Adoption of such strategies by key players in the market is anticipated to drive the market growth. 

However, blepharoplasty is a non-surgical procedure considered safe and effective, but as with any surgery, there are risks and potential complications. These can include infection, bleeding, scarring, changes in vision, and improper volumes applications. For instance, according to an article published by National library of medicine (NCBI), in April 2021, reported that patients treated with injections of hyaluronic acid filler suffered from a sense of heaviness and asthenopia, and cosmetic concerns, which limit the adoption of these surgeries and negatively impact the market growth. 

On the basis of type, the blepharoplasty industry is categorized into upper eyelid surgery, lower eyelid surgery and combination eyelid surgery. The upper eyelid surgery segment accounted for the largest blepharoplasty market share in 2021. Most of the patients prefer upper eyelid surgery because it offers improved vision, less double vision, and a more youthful appearance.  

However, lower eyelid surgery is anticipated to grow with a significant CAGR during the forecast period. Owing to rise in awareness for blepharoplasty and to reduce wrinkles, puffiness, drooping eyelids and other signs of aging.  

On the basis of gender, the blepharoplasty industry is bifurcated into female and male. The female segment is anticipated to be the largest segment during the forecast period owing to rise in aging population, blepharoplasty can help to reverse the signs of aging, giving women a more youthful appearance.  

On the basis of service provider, the market is classified into hospital, clinics, and ambulatory surgical centers. The hospital segment dominated the market in 2021 owing to, increase in the number of hospitals providing surgical procedures for eyelid with the help of technologically advanced medical devices and rise in the number of patients undergoing cosmetical surgeries from hospital facilities. However, the clinics segment is anticipated to grow with a significant CAGR during the forecast period. This is attributed to the availability of advanced equipment and well-trained healthcare staff.  

On the basis of region, North America has the highest blepharoplasty market share in 2021 and is expected to maintain its lead during the forecast period, owing to the availability of improved facilities and the growth in demand for cosmetic surgery from the large adult and geriatric population. However, Asia-Pacific is expected to exhibit the fastest growth during the forecast period, owing to an increase in the number of patients undergoing eyelid surgery, improvement in health awareness, development in healthcare facilities, and surge in healthcare expenditure.

The overall impact of COVID-19 remains negative on the blepharoplasty market owing to restrictions across all over the world and social distancing protocols, which have disrupted access to healthcare services and reduced the number of patients opting for blepharoplasty. 

KEY FINDINGS OF THE STUDY 

• By type, the upper eyelid blepharoplasty segment was the highest contributor to the market in 2021. 

• By gender, the female segment was the highest contributor to the market in 2021. 

• By service provider, the hospitals segment was the highest contributor to the market in 2021. 

• By region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR of 8.8% during the forecast period.